GE HealthCare advances Signa MRI portfolio with trio of FDA clearances
GE HealthCare’s recently release financials for full year 2025 reveal that the company’s imaging vertical contributed almost 50% of its...
FDA
GE HealthCare’s SIGNA MRI Portfolio Granted FDA Clearance
Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food...
GE HealthCare wins FDA clearance for Allia Moveo interventional imaging system
GE HealthCare has received U.S. Food and Drug Administration 510(k) clearance and CE Marking for Allia Moveo, a new mobile...
GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark
Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
GE HealthCare’s Allia Moveo gains FDA and CE mark approvals
GE HealthCare’s Allia Moveo system GE HealthCare has announced that its Allia Moveo image-guidance platform has received US Food and...
GE HealthCare submits next-gen MRI to FDA, unveils new Allia
The Signa 3T MRI scanner. GE HealthCare (Nasdaq: GEHC) + announced that it submitted its next-generation Signa MRI technology to...
GE HealthCare submits AI-powered photon CT system to FDA
The Photonova Spectra system. GE HealthCare (Nasdaq: GEHC) + announced today that it submitted its Photonova Spectra system with advanced...
FDA removes warning label from hormone therapy
Menopause care is lacking, leading to delays in care experts sayDr. Stephanie Faubion of the Menopause Society says medical schools...
GE Healthcare Tops FDA List of AI Authorizations
July 22, 2025 — GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device...
